Valuation AbbVie Inc.

Stocks

Market Closed - NYSE Other stock markets 01:34:22 17/07/2026 am IST			Pre-market 04:49:12 pm
254.39 ^USD	+4.21%		255.88	+0.58%

16/07	Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal	RE
16/07	Global markets live: Google, Stripe, xAI, Apple, Eli Lilly…

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,39,371	2,85,707	2,73,605	3,14,021	4,03,830	4,49,454	-	-
Change	-	19.36%	-4.24%	14.77%	28.6%	11.3%	-	-
Enterprise Value (EV) ¹	3,06,225	3,39,749	3,20,176	3,75,610	4,63,570	5,05,842	4,97,329	4,85,073
Change	-	10.95%	-5.76%	17.31%	23.42%	9.12%	-1.68%	-2.46%
P/E	21x	24.4x	57x	74.4x	96.8x	33.1x	23.5x	20.2x
PBR	15.5x	16.6x	26.5x	94.8x	-124x	12,663x	58.5x	25.6x
PEG	-	8.74x	-1x	-6.1x	-77.12x	0x	0.6x	1.2x
Capitalization / Revenue	4.27x	4.92x	5.04x	5.57x	6.6x	6.68x	6.17x	5.74x
EV / Revenue	5.46x	5.85x	5.89x	6.67x	7.58x	7.52x	6.83x	6.19x
EV / EBITDA	10.6x	11x	12.5x	15.6x	18.9x	15.4x	13.4x	11.8x
EV / EBIT	10.9x	11.3x	12.9x	16.1x	19.5x	15.9x	13.6x	12.1x
EV / FCF	13.9x	14x	14.5x	21.1x	26x	16.4x	14.8x	14x
FCF Yield	7.18%	7.14%	6.89%	4.75%	3.84%	6.09%	6.75%	7.14%
Dividend per Share ²	5.31	5.71	5.99	6.29	6.65	6.87	7.234	7.637
Rate of return	3.92%	3.53%	3.87%	3.54%	2.91%	2.7%	2.84%	3%
EPS ²	6.45	6.63	2.72	2.39	2.36	7.676	10.81	12.62
Distribution rate	82.3%	86.1%	220%	263%	282%	89.5%	66.9%	60.5%
Net sales ¹	56,122	58,054	54,318	56,334	61,160	67,251	72,811	78,308
EBITDA ¹	29,018	30,961	25,545	24,104	24,483	32,790	37,147	41,114
EBIT ¹	28,215	30,183	24,793	23,340	23,721	31,743	36,456	40,130
Net income ¹	11,542	11,836	4,863	4,278	4,226	14,437	18,983	22,096
Net Debt ¹	66,854	54,042	46,571	61,589	59,740	56,388	47,875	35,619
Reference price ²	135.40	161.61	154.97	177.70	228.49	254.39	254.39	254.39
Nbr of stocks (in thousands)	17,67,880	17,67,880	17,65,537	17,67,140	17,67,385	17,66,793	-	-
Announcement Date	02/02/22	09/02/23	02/02/24	31/01/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBVIE INC.	33.14x	7.52x	15.43x	2.7%	45TCr
ELI LILLY AND COMPANY	34.75x	12.42x	25.87x	0.58%	1,04300Cr
JOHNSON & JOHNSON	26.86x	6.13x	16.78x	2.15%	60TCr
ROCHE HOLDING AG	17.71x	4.39x	10.82x	3.02%	33TCr
NOVARTIS AG	21.31x	5.47x	13.24x	2.89%	28TCr
ASTRAZENECA PLC	21.26x	4.48x	12.39x	1.96%	26TCr
AMGEN INC.	24.37x	6.42x	11.35x	2.71%	20TCr
GILEAD SCIENCES, INC.	-49.1x	5.86x	32.41x	2.38%	17TCr
PFIZER INC.	12.77x	3.12x	7.88x	6.86%	14TCr
VERTEX PHARMACEUTICALS INCORPORATED	27.8x	8.4x	18.93x	-.--%	12TCr
Average	17.09x	6.42x	16.51x	2.53%	36TCr
Weighted average by Cap.	24.02x	7.76x	18.26x	2.04%